Ledger.Open graph →
SEC Form D · filed February 6, 2015

AGILE THERAPEUTICS INC

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PRINCETON, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Scott M. Coiante · Princeton, NJExecJames P. Tursi · Princeton, NJDirectorAbhijeet P. Lele · Princeton, NJDirectorWilliam T. Mckee · Princeton, NJDirectorJohn S. Hubbard · Princeton, NJDirectorElizabeth M. Garner · Princeton, NJExecAl Altomari · Princeton, NJExec · DirectorKatie M. Macfarlane · Princeton, NJExecKaren M. Hong · Princeton, NJDirectorAndrew N. Schiff · Princeton, NJDirectorPeter Fenton · San Francisco, CADirectorJerry Chen · San Francisco, CAExecJerry Yang · San Francisco, CADirectorMichael Masquelier · Salt Lake City, UTDirectorSolomon Hykes · San Francisco, CAExec · DirectorBenjamin Golub · San Francisco, CAExec · DirectorMarc Verstaen · San Francisco, CAExec · DirectorDaniel Scholnick · San Francisco, CADirectorEric Candino · New York, NYExecBenjamin Darr · New York, NYExec · DirectorJonathan Widlitz · New York, NYDirectorVance C. Brown · New York, NYExecDalton Wright · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗